MelaFind® – Washington, D.C.
The Washington Institute of Dermatologic Laser Surgery is the first practice in the Washington, DC Metro area to offer MelaFind®. MelaFind® is a new medical technology that was approved by the FDA to help dermatologists see under the skin’s surface in order to better determine whether a skin lesion is malignant. The device collects information 2.5mm deep into the skin in a painless and non-invasive manner by using computer vision technology.
This objective system helps the physician to render a decision regarding biopsy and removal of irregular moles and detecting early-stage melanoma. This is particularly useful on the face and other areas where a biopsy would be a cosmetic concern.
Melanoma is the most deadly form of skin cancer, and everyone is at risk. If caught early with regular self exams and a yearly skin exam with a dermatologist, melanoma has an excellent cure rate and long-term survival rate. If you have a new or suspicious mole that you would like examined and/or removed, please schedule a consultation at the Washington Institute of Dermatologic Laser Surgery in Washington, D.C. today.